Home | Clinical Cancer Research

Read the December 15 issue!
The cover shows a patient-derived neuroblastoma xenograft sphere infiltrated by human IL-15–activated NK cells. For details, see the article by Nguyen and colleagues.
$Read: Phase I Study of Rapid Alternation of Sunitinib and Regorafenib for the Treatment of Tyrosine Kinase Inhibitor Refractory Gastrointestinal Stromal Tumors, César Serrano, et al.$
Clinical Trials: Targeted Therapy
Read: Phase I Study of Rapid Alternation of Sunitinib and Regorafenib for the Treatment of Tyrosine Kinase Inhibitor Refractory Gastrointestinal Stromal Tumors, César Serrano, et al.
CCR Translation
Read: A New Pathway Emerges to Interpret Lung Cancer Genomic Alterations, Collin M. Blakely.
New Researcher Behind the Journals profile!
Read about Jason J. Luke, Senior Editor of the Journal.

From the Current Issue

Clinical Trials: Targeted Therapy

Phase I Study of Rapid Alternation of Sunitinib and Regorafenib for the Treatment of Tyrosine Kinase Inhibitor Refractory Gastrointestinal Stromal Tumors

César Serrano, Alessandro Leal, Yanan Kuang, Jeffrey A. Morgan, Constance M. Barysauskas, Jillian Phallen, Olivia Triplett, Adrián Mariño-Enríquez, Andrew J. Wagner, George D. Demetri, Victor E. Velculescu, Cloud P. Paweletz, Jonathan A. Fletcher and Suzanne George

Clin Cancer Res December 15 2019 25 (24) 7287-7293; DOI:10.1158/1078-0432.CCR-19-2150
Clinical Trials: Targeted Therapy

Efficacy and Safety of Dabrafenib in Pediatric Patients with BRAF V600 Mutation–Positive Relapsed or Refractory Low-Grade Glioma: Results from a Phase I/IIa Study

Darren R. Hargrave, Eric Bouffet, Uri Tabori, Alberto Broniscer, Kenneth J. Cohen, Jordan R. Hansford, Birgit Geoerger, Pooja Hingorani, Ira J. Dunkel, Mark W. Russo, Lillian Tseng, Kohinoor Dasgupta, Eduard Gasal, James A. Whitlock and Mark W. Kieran

Clin Cancer Res December 15 2019 25 (24) 7303-7311; DOI:10.1158/1078-0432.CCR-19-2177
Clinical Trials: Immunotherapy | AuthorChoice

Guadecitabine Plus Ipilimumab in Unresectable Melanoma: The NIBIT-M4 Clinical Trial

Anna Maria Di Giacomo, Alessia Covre, Francesca Finotello, Dietmar Rieder, Riccardo Danielli, Luca Sigalotti, Diana Giannarelli, Florent Petitprez, Laetitia Lacroix, Monica Valente, Ornella Cutaia, Carolina Fazio, Giovanni Amato, Andrea Lazzeri, Santa Monterisi, Clelia Miracco, Sandra Coral, Andrea Anichini, Christoph Bock, Amelie Nemc, Aram Oganesian, James Lowder, Mohammad Azab, Wolf H. Fridman, Catherine Sautès-Fridman, Zlatko Trajanoski and Michele Maio

Clin Cancer Res December 15 2019 25 (24) 7351-7362; DOI:10.1158/1078-0432.CCR-19-1335
Precision Medicine and Imaging

Impact of FDG PET Imaging for Expanding Patient Eligibility and Measuring Treatment Response in a Genome-Driven Basket Trial of the Pan-HER Kinase Inhibitor, Neratinib

Gary A. Ulaner, Cristina Saura, Sarina A. Piha-Paul, Ingrid Mayer, David Quinn, Komal Jhaveri, Ben Stone, Seta Shahin, Grace Mann, Melanie Dujka, Richard Bryce, Funda Meric-Bernstam, David B. Solit and David M. Hyman

Clin Cancer Res December 15 2019 25 (24) 7381-7387; DOI:10.1158/1078-0432.CCR-19-1658

See the Table of Contents

Main menu

User menu

Search

From the Current Issue

OnlineFirst Articles

Articles

Info for

About Clinical Cancer Research